ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

DeVita Emphasizes NCI Prevention In Statement To Senate Committee

February 15, 1980

Cooperative Groups, NCI To Talk About Overlaps

March 14, 1975

NCI Critics Take Their Best Shots, Seek New Emphasis On Prevention At Kennedy Hearings

March 16, 1979

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

Satcher Nominated For Surgeon General, Asst. Sec. for Health.

September 19, 1997

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001